Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Perspective Therapeutics (CATX) Tax Provisions (2023)

Perspective Therapeutics (CATX) has disclosed Tax Provisions for 1 consecutive years, with $7.8 million as the latest value for Q4 2023.

  • Quarterly Tax Provisions changed N/A to $7.8 million in Q4 2023 from the year-ago period, while the trailing twelve-month figure was -$2.7 million through Dec 2023, changed N/A year-over-year, with the annual reading at -$2.7 million for FY2023, N/A changed from the prior year.
  • Tax Provisions hit $7.8 million in Q4 2023 for Perspective Therapeutics, up from -$10.5 million in the prior quarter.
  • In the past five years, Tax Provisions ranged from a high of $7.8 million in Q4 2023 to a low of -$10.5 million in Q1 2023.